Dresden, Germany

Artificial intelligence-generated synthetic data for cancer research and clinical trials

Image-based explainable AI accurately identifies myelodysplastic neoplasms beyond conventional signs of dysplasia

Generating reliable synthetic clinical trial data

AI for risk assessment and outcome prediction in malignant haematology

Differential prognostic impact of myelodysplasia-related gene mutations in AML

Promises and challenges of AI in haematological diagnostics

AML diagnostics in the 21st century: Use of AI

Towards Accurate Risk Prediction in Leukemia

Synthetic Microscopy Image Data Augments Leukemia Detection Models

See you in San Diego! #ASH2024